[1]
“New-Onset Diabetes in the Post-COVID-19 Era: Clinical Characteristics, Underlying Mechanisms, and Long-Term Metabolic Outcomes”, FJHMS, vol. 1, no. 3, pp. 237–244, Sep. 2025, doi: 10.46649/3gtsf010.